期刊文献+

帕罗西汀对轻-中度溃疡性结肠炎伴焦虑/抑郁的疗效评价 被引量:8

Efficacy assessment of paroxetine in the treatment of patients with mild-to-moderate ulcerative colitis accompanied with anxiety/depression
下载PDF
导出
摘要 目的评价帕罗西汀辅助治疗轻-中度溃疡性结肠炎伴焦虑/抑郁的疗效。方法将30例轻-中度溃疡性结肠炎(UC)伴焦虑/抑郁患者随机分成2组(每组15例),分别接受5-氨基水杨酸和5-氨基水杨酸+帕罗西汀治疗;所有患者治疗前后均进行临床活动指数(CAI)、内镜指数(EI)和焦虑/抑郁测试,并比较治疗后的改善情况。结果治疗后5-氨基水杨酸+帕罗西汀组的CAI(腹泻和腹痛)和焦虑/抑郁评分较5-氨基水杨酸组显著下降(P<0.05,P<0.001),而EI和其他表现与5-氨基水杨酸组无显著差异(P>0.05)。结论对于轻-中度UC伴焦虑/抑郁的患者,帕罗西汀能改善焦虑/抑郁,通过减轻腹泻和腹痛而促进临床缓解,可作为辅助用药之一,但对组织学表现无改善作用。 ate ulcerative Objective To assess the efficacy of paroxetine in the adjuvant treatment of patients with mild-to-moder- colitis (UC) accompanied with anxiety/depression. Methods 30 patients diagnosed with mild-to-modeL- ate UC accompanied with anxiety/depression were assigned into two groups (15 ones in each group) randomly, and were treated with 5-aminosalicylic acid and 5-aminosalicylic acid combined with paroxetine, respectively. Clinical activi- ty index (CAI), endoscopic index (EI), and anxiety/depression tests were performed before and after the treatment, and the efficacy of treatment was compared. Results The difference was significant between two groups with respect to CAI (diarrhea and abdominal pain) and anxiety/depression scoring after the treatment (P 〈 0. 05, P 〈 0. 001 ), but there was no difference with respect to EI and other items (P 〉 0.05). Conclusion Paroxetine can improve anxiety/ depression, and accelerate the clinical remission through attenuating diarrhea and abdominal pain. Therefore, it might be an adjuvant treatment for patients with mild-to-moderate UC accompanied with anxiety/depression. However, it can not improve the histologic appearance.
出处 《胃肠病学和肝病学杂志》 CAS 2012年第5期441-443,共3页 Chinese Journal of Gastroenterology and Hepatology
关键词 溃疡性结肠炎 帕罗西汀 焦虑 抑郁 疗效分析 Ulcerative colitis Paroxetine Anxiety Depression Efficacy assessment
  • 相关文献

参考文献17

  • 1欧阳钦,胡品津,钱家鸣,郑家驹,胡仁伟.对我国炎症性肠病诊断治疗规范的共识意见[J].胃肠病学,2007,12(8):488-495. 被引量:751
  • 2Rachmilewitz D. Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial [J]. BMJ, 1989, 298(6666): 82-86. 被引量:1
  • 3Arfaoui D, Elloumi H, Debbebi W, et al. Psychological disorder associated to inflammatory bowel disease [ J]. Tunis Med, 2007, 85 (3) : 189-191. 被引量:1
  • 4Mawdsley JE, Rampton DS. Psychological stress in IBD: new insights into pathogenic and therapeutic implications [ J ]. Gut, 2005, 54 (10): 1481-1491. 被引量:1
  • 5Hauser W, Janke KH, Klump B, et al. Anxiety and depression in pa- tients with inflammatory bowel disease: comparisons with chronic liver disease patients and the general population [ J ]. Inflamm Bowel Dis, 2011, 17(2) : 621-632. 被引量:1
  • 6程文芳,施瑞华.溃疡性结肠炎患者心理特征的研究[J].胃肠病学和肝病学杂志,2007,16(5):437-439. 被引量:29
  • 7Fuller-Thomson E, Sulman J. Depression and inflammatory bowel disease: findings from two nationally representative Canadian surveys [ J ]. Inflamm Bowel Dis, 2006, 12(8) : 697-707. 被引量:1
  • 8Mittermaier C, Dejaco C, Waldhoer T, et al. Impact of depressive mood on relapse in patients with inflammatory bowel disease: a prospective 18-month follow-up study [ J]. Psychosom Med, 2004, 66 ( 1 ) : 79-84. 被引量:1
  • 9Mikocka-Walus AA, Turnbull DA, Moulding NT, et al. " It doesnt do any harm, but patients feel better" : a qualitative exploratory study on gastroenterologists" perspectives on the role of antidepressants in inflammatory bowel disease [J]. BMC Gastroenterol, 2007, 7: 38. 被引量:1
  • 10Mikocka-Walus AA, Turnbull DA, Moulding NT, et al. Antidepressants and inflammatory bowel disease: a systematic review [ J]. Clin Pract Epidemiol Ment Health, 2006, 2: 24. 被引量:1

二级参考文献26

  • 1潘国宗 刘彤华 见:潘国宗 曹世植9. 主编.溃疡性结肠炎[A].见:潘国宗,曹世植9.,主编.现代胃肠病学.第Ⅰ版[C].北京:科学出版社,1994.1246-1247. 被引量:5
  • 2潘国宗 刘彤华.Crohn病[A].见:潘国宗 曹世植 主编.现代胃肠病学[C].北京:科学出版社,1994.1154. 被引量:3
  • 3Ouyang Q,Tandon R,Goh KL,et al.The emergence of inflammatory bowel disease in the Asian Pacific region.Curr Opin Gastroenterol,2005,21 (4):408-413. 被引量:1
  • 4Satsangi J,Silverberg MS,Vermeire S,et al.The Montreal classification of inflammatory bowel disease:controversies,consensus,and implications.Gut,2006,55(6):749-753. 被引量:1
  • 5Kornbluth A,Sachar DB; Practice Parameters Committee of the American College of Gastroenterology.Ulcerative colitis practice guidelines in adults (update):American College of Gastroenterology,Practice Parameters Committee.Am J Gastroenterol,2004,99 (7):1371-1385. 被引量:1
  • 6Hanauer SB,Sandborn W; Practice Parameters Committee of the American College of Gastroenterology.Management of Crohn's disease in adults.Am J Gastroenterol,2001,96 (3):635-643. 被引量:1
  • 7Stange EF,Travis SP,Vermeire S,et al.European Crohn's and Colitis Organisation.European evidence based consensus on the diagnosis and management of Crohn's disease:definitions and diagnosis.Gut,2006,55Suppl 1:i1-i15. 被引量:1
  • 8Carter MJ,Lobo AJ,Travis SP; IBD Section,British Society of Gastroenterology.Guidelines for the management of inflammatory bowel disease in adults.Gut,2004,53 Suppl 5:V1-V16. 被引量:1
  • 9Shivananda S,Hordijk ML,Ten Kate FJ,et al.Differential diagnosis of inflammatory bowel disease.A comparison of various diagnostic classifications.Scand J Gastroenterol,1991,26 (2):167-173. 被引量:1
  • 10樋渡信夫 渡边浩光 前川浩树 等.溃疡性结肠炎的诊断标准与诊断进展[J].炎症性肠疾患胃与肠,1997,32(3):271-278. 被引量:3

共引文献772

同被引文献73

引证文献8

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部